Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

A second study has linked semaglutide, the active ingredient in Ozempic, to a condition that can cause permanent vision loss.

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

Semaglutide and other GLP-1 meds slow the rate at which food empties from your stomach, and that leaves you feeling full ...

Financial analyst assesses the credit market concerns and declining operating results for WW International, with insight on ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

Tiny doses of the weight-loss drug can sidestep its unpleasant side effects, say influencers. But is customising the dose a ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the ...